134 related articles for article (PubMed ID: 8263928)
1. Crystallization of inhibited aspartic proteinase from Candida albicans.
Cutfield S; Marshall C; Moody P; Sullivan P; Cutfield J
J Mol Biol; 1993 Dec; 234(4):1266-9. PubMed ID: 8263928
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors.
Cutfield SM; Dodson EJ; Anderson BF; Moody PC; Marshall CJ; Sullivan PA; Cutfield JF
Structure; 1995 Nov; 3(11):1261-71. PubMed ID: 8591036
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.
Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C
Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase.
Tolley S; Davies G; Hubbard RE; Smith DJ; Proudfoot AE; Payton MA; Cleasby A; Wonacott A; Wells TN
J Mol Biol; 1994 Apr; 237(3):349-50. PubMed ID: 8145246
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A.
Borelli C; Ruge E; Schaller M; Monod M; Korting HC; Huber R; Maskos K
Proteins; 2007 Aug; 68(3):738-48. PubMed ID: 17510964
[TBL] [Abstract][Full Text] [Related]
6. Crystallization and preliminary crystallographic characterization of aspartic proteinase-A from baker's yeast and its complexes with inhibitors.
Badasso M; Wood SP; Aguilar C; Cooper JB; Blundell TL; Dreyer T
J Mol Biol; 1993 Jul; 232(2):701-3. PubMed ID: 8345528
[TBL] [Abstract][Full Text] [Related]
7. Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.
Trabocchi A; Mannino C; Machetti F; De Bernardis F; Arancia S; Cauda R; Cassone A; Guarna A
J Med Chem; 2010 Mar; 53(6):2502-9. PubMed ID: 20184325
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary X-ray investigation of recombinant simian immunodeficiency virus proteinase.
Wilderspin AF; Sugrue RJ
J Mol Biol; 1993 Jun; 231(4):1139-42. PubMed ID: 8515473
[TBL] [Abstract][Full Text] [Related]
10. X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans.
Borelli C; Ruge E; Lee JH; Schaller M; Vogelsang A; Monod M; Korting HC; Huber R; Maskos K
Proteins; 2008 Sep; 72(4):1308-19. PubMed ID: 18384081
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution.
Kamitori S; Ohtaki A; Ino H; Takeuchi M
J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261
[TBL] [Abstract][Full Text] [Related]
12. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M
Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463
[TBL] [Abstract][Full Text] [Related]
13. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors.
Suguna K; Padlan EA; Bott R; Boger J; Parris KD; Davies DR
Proteins; 1992 Jul; 13(3):195-205. PubMed ID: 1603809
[TBL] [Abstract][Full Text] [Related]
14. Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.
Degel B; Staib P; Rohrer S; Scheiber J; Martina E; Büchold C; Baumann K; Morschhäuser J; Schirmeister T
ChemMedChem; 2008 Feb; 3(2):302-15. PubMed ID: 18038380
[TBL] [Abstract][Full Text] [Related]
15. Crystallization and preliminary X-ray diffraction analysis of the beta-chain of a T-cell antigen receptor.
Boulot G; Bentley GA; Karjalainen K; Mariuzza RA
J Mol Biol; 1994 Jan; 235(2):795-7. PubMed ID: 8289304
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary X-ray structure solution of Rhizomucor miehei aspartic proteinase.
Jia Z; Vandonselaar M; Schneider P; Quail JW
Acta Crystallogr D Biol Crystallogr; 1995 Mar; 51(Pt 2):243-4. PubMed ID: 15299327
[TBL] [Abstract][Full Text] [Related]
17. Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution.
Yang J; Quail JW
Acta Crystallogr D Biol Crystallogr; 1999 Mar; 55(Pt 3):625-30. PubMed ID: 10089458
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.
Backman D; Danielson UH
Biochim Biophys Acta; 2003 Mar; 1646(1-2):184-95. PubMed ID: 12637026
[TBL] [Abstract][Full Text] [Related]
19. Crystallization of nepenthesin I using a low-pH crystallization screen.
Fejfarová K; Kádek A; Mrázek H; Hausner J; Tretyachenko V; Koval' T; Man P; Hašek J; Dohnálek J
Acta Crystallogr F Struct Biol Commun; 2016 Jan; 72(Pt 1):24-8. PubMed ID: 26750480
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary X-ray crystallographic studies of dissimilatory nitrite reductase isolated from Hyphomicrobium denitrificans A3151.
Xie Y; Inoue T; Seike N; Matsumura H; Kanbayashi K; Itoh K; Kataoka K; Yamaguchi K; Suzuki S; Kai Y;
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2383-6. PubMed ID: 15583395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
